Periodic Reporting for period 1 - PORTAL (Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX))

Lymphomas are a group of heterogenous blood cancers that arise from B or T lymphocytes and occur in 12 cases in 100,000 inhabitants each year. The most frequent B cell lymphomas are B-cell non-Hodgkin’s lymphomas (B-NHL). The 50% of B-NHL patients are refractory or relapse...